J. Meijers

发表

Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.

J. Berkhof, V. V. van Hinsbergh, M. Levi, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of isoleucine residues 182 and 183 in thrombin‐activatable fibrinolysis inhibitor

B. Bouma, S. Havik, J. Meijers, 2005, Journal of thrombosis and haemostasis : JTH.

Inactivation of Active Thrombin-activable Fibrinolysis Inhibitor Takes Place by a Process That Involves Conformational Instability Rather Than Proteolytic Cleavage*

J. Griffin, P. Dawson, J. Meijers, 2000, The Journal of Biological Chemistry.

UvA-DARE ( Digital Academic Repository ) Diagnosis , treatment and long-term effects of venous thromboembolism

S. Middeldorp, B. Hutten, M. Coppens, 2016 .

In vivo increase in thrombin generation by four‐factor prothrombin complex concentrate in apixaban‐treated healthy volunteers

S. Middeldorp, B. Hutten, M. Coppens, 2015, Journal of thrombosis and haemostasis : JTH.

Coagulation factor XI as a novel target for antithrombotic treatment

B. Monia, M. Levi, J. Meijers, 2010, Journal of thrombosis and haemostasis : JTH.

Analysis of Coagulation Cascade and Endothelial Cell Activation During Inhibition of Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Pathway in Cancer Patients

V. V. van Hinsbergh, M. Levi, P. Kostense, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.

P. Reitsma, M. Zago, W. Silva, 2001, Haematologica.

Venous thrombosis is associated with hyperglycemia at diagnosis: a case–control study

H. Büller, J. DeVries, J. Hoekstra, 2009, Journal of thrombosis and haemostasis : JTH.

Protein C and S and inflammation in sickle cell disease

A. Duits, H. ten Cate, A. V. van Zanten, 2004, American journal of hematology.

Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin‐activatable fibrinolysis inhibitor

I. B. Borel Rinkes, E. Voest, G. Wagenaar, 2003, Journal of thrombosis and haemostasis : JTH.

The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

F. Rosendaal, J. F. van der Heijden, A. A. Garcia, 2006, Journal of thrombosis and haemostasis : JTH.

The effects of an extremely high dose of levothyroxine on coagulation and fibrinolysis

A. Squizzato, H. Otten, J. Meijers, 2010, Journal of thrombosis and haemostasis : JTH.

Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram‐negative sepsis (melioidosis)

T. van der Poll, W. Wiersinga, T. Poll, 2011, Journal of thrombosis and haemostasis : JTH.

UvA-DARE ( Digital Academic Repository ) Factor XI as target for antithrombotic therapy

S. Middeldorp, S. Zeerleder, B. Hutten, 2014 .

Analysis of tumour-localizing haematoporphyrin derivative by high-performance liquid chromatography and fast-atom bombardment mass spectrometry.

C. Lim, T. Peters, A. Lawson, 1986, Journal of chromatography.

University of Birmingham Atherothrombosis and Thromboembolism :

T. Renné, H. Crijns, N. Mackman, 2018 .

Activation of coagulation system during air travel: a crossover study

F. Rosendaal, S. Middeldorp, J. Meijers, 2006, The Lancet.

Statin therapy and levels of hemostatic factors in a healthy population: the Multi‐Ethnic Study of Atherosclerosis: a rebuttal

M. Trip, G. Hovingh, B. Hutten, 2013, Journal of thrombosis and haemostasis : JTH.

The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency

A. Gils, H. Lijnen, M. Peeters, 2012, Journal of thrombosis and haemostasis : JTH.

The prognostic value of the D‐dimer test in cancer patients treated with and without low‐molecular‐weight heparin

H. Büller, M. Di Nisio, J. Meijers, 2005, Journal of thrombosis and haemostasis : JTH.

Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure

R. Porte, R. Stravitz, J. Meijers, 2012, Journal of thrombosis and haemostasis : JTH.

Platelet-vessel wall interaction in health and disease.

M. Levi, J. Meijers, E. Löwenberg, 2010, The Netherlands journal of medicine.

Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis

T. van der Poll, W. Wiersinga, T. Poll, 2007, Journal of thrombosis and haemostasis : JTH.

Explanations for coagulation activation after air travel

H. Büller, F. Rosendaal, S. Middeldorp, 2010, Journal of thrombosis and haemostasis : JTH.

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

P. A. von dem Borne, B. Bouma, J. Meijers, 2006, Journal of thrombosis and haemostasis : JTH.

Chapter 6 Explanations for coagulation activation after air travel

S. Middeldorp, H. Lijnen, J. Meijers, 2009 .

Development of a Hyperactive Primary Hemostatic System During Off‐Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13

R. Porte, T. Lisman, M. Erasmus, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anticoagulant and anti‐inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis

M. Boermeester, T. V. van Gulik, J. Meijers, 2006, Journal of thrombosis and haemostasis : JTH.

Development of sandwich‐type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasma

A. Gils, P. Declerck, J. Meijers, 2007, Journal of thrombosis and haemostasis : JTH.

Tumor growth and metastasis are not affected in thrombin‐activatable fibrinolysis inhibitor‐deficient mice

E. Voest, J. Meijers, B. Bouma, 2004, Journal of thrombosis and haemostasis : JTH.

Review: Viral infections and mechanisms of thrombosis and bleeding†

E. V. van Gorp, M. Goeijenbier, D. Brandjes, 2012, Journal of medical virology.

UvA-DARE ( Digital Academic Repository ) Hormones , haemostasis , and the risk of thrombosis

O. Dekkers, H. Büller, V. Gerdes, 2010 .

Intact thrombomodulin‐mediated regulation of fibrinolysis during and after liver transplantation, despite a profoundly defective thrombomodulin‐mediated regulation of coagulation

R. Porte, J. Meijers, T. Lisman, 2010, Journal of thrombosis and haemostasis : JTH.

Procoagulant protein levels are differentially increased during human endotoxemia

T. van der Poll, P. Reitsma, J. Meijers, 2003, Journal of thrombosis and haemostasis : JTH.

Hyperglycemia: a prothrombotic factor?

J H Devries, J. DeVries, F. Holleman, 2010, Journal of thrombosis and haemostasis : JTH.

β2‐Glycoprotein I: evolution, structure and function

P. D. de Groot, J. Meijers, J. Meijers, 2011, Journal of thrombosis and haemostasis : JTH.

Use of an absorbable embolization material for reversible portal vein embolization in an experimental model

T. V. van Gulik, J. Verheij, M. Heger, 2016, The British journal of surgery.

Effects of Second and Third Generation Oral Contraceptives and their Respective Progestagens on the Coagulation System in the Absence or Presence of the Factor V Leiden Mutation

A. Algra, D. Grobbee, D. Grobbee, 2002, Thrombosis and Haemostasis.

EFFECT OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR PAROXETINE ON PLATELET FUNCTION IS MODIFIED BY A SLC6A4 SEROTONIN TRANSPORTER POLYMORPHISM

A. Schene, H. Büller, H. Ruhé, 2009 .

Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats

T. van der Poll, T. Poll, A. D. de Vos, 2006, Journal of thrombosis and haemostasis : JTH.

ApoAI‐phosphatidylcholine infusion neutralizes the atherothrombotic effects of C‐reactive protein in humans

J. Kuivenhoven, J. Levels, R. Basser, 2009, Journal of thrombosis and haemostasis : JTH.

Identification of polymorphisms in the TAFI gene promoter: Relationship with plasma TAFI levels and risk of venous thrombosis.

P. Reitsma, M. Zago, W. Silva, 2000 .

Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux

P. D. de Groot, M. Levi, H. Nieuwenhuis, 2003, Journal of thrombosis and haemostasis : JTH.

Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time

P. D. de Groot, P. Kamphuisen, P. Kamphuisen, 2011, Journal of thrombosis and haemostasis : JTH.

Recent developments in our understanding of the antiphospholipid syndrome

P. D. de Groot, R. Urbanus, J. Meijers, 2012, International journal of laboratory hematology.

Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients

T. Renné, B. Bouma, A. Squizzato, 2011, Journal of thrombosis and haemostasis : JTH.

Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation

A. Algra, D. Grobbee, D. Grobbee, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Increased sperm count may account for high population frequency of factor V Leiden

H. Büller, S. Middeldorp, S. Repping, 2010, Journal of Thrombosis and Haemostasis.

The activation peptide of thrombin‐activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

M. Mörgelin, J. Meijers, S. Havik, 2009, Journal of thrombosis and haemostasis : JTH.

The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women

A. Reiner, T. Lumley, S. Heckbert, 2006, Journal of thrombosis and haemostasis : JTH.

Urokinase receptor is necessary for bacterial defense against Gram-negative sepsis (melioidosis) by facilitating phagoctytosis

W. Wiersinga, T. Poll, M. Levi, 2009, Critical Care.

Thrombin‐activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

J. Meijers, B. Bouma, J. Meijers, 2003, Journal of thrombosis and haemostasis : JTH.

Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency.

E. Davie, J. Meijers, D. Chung, 1992, Blood.

Periodontitis is associated with platelet activation

B. Loos, E. Nicu, S. Bizzarro, 2008 .

Selective modulation of thrombin‐activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin‐thrombomodulin complex using TAFI‐derived peptides

J. Marquart, J. Meijers, J. Meijers, 2015, Journal of thrombosis and haemostasis : JTH.

New clues regarding the mysterious mechanism of activated thrombin‐activatable fibrinolysis inhibitor self‐destruction

J. Meijers, J. Meijers, T. Plug, 2015, Journal of thrombosis and haemostasis : JTH.

A role for arginine‐12 in thrombin–thrombomodulin‐mediated activation of thrombin‐activatable fibrinolysis inhibitor

J. Meijers, T. Plug, G. Kramer, 2014, Journal of thrombosis and haemostasis : JTH.

Oral contraceptives reduce total protein S, but not free protein S.

W. Erich, J. Meijers, B. Bouma, 1987, Thrombosis research.